作者: Paul M. Magtibay , Kirk D. Ramin , Denise Y. Harris , Patrick S. Ramsey , Paul L. Ogburn
DOI: 10.1002/(SICI)1520-6661(199801/02)7:1<15::AID-MFM4>3.0.CO;2-U
关键词:
摘要: The objective of this investigation was to compare the efficacy, safety, and cost intravaginal misoprostol as a labor induction agent standard protocol using prostaglandin E2 (Prepidil) intravenous oxytocin. Thirty-eight patients requiring with an unfavorable cervix (Bishop score ≤5) were prospectively randomized receive either 50 mcg every 4 hours until delivery, or single dose PGE2 gel (0.5 mg) followed by oxytocin infusion. Changes in Bishop scores recorded blinded fashion. Clinical outcomes compared two groups, including induction-to-delivery times cesarean section rates. Seventeen women treated misoprostol, 19 received PGE2/oxytocin, dropped out study. groups did not differ significantly respect age, parity, gestational weight, height, reason for induction, initial score. There significant difference median change sco...